Microscopy & Imaging: Page 3

Predictive Health acquires Muse Microscopy

By LabPulse.com staff writers

Muse's technology, microscopy with ultraviolet surface excitation (MUSE), uses short-wavelength ultraviolet (UV) light to penetrate just microns deep into tissue and eliminates the need for precision-cut thin specimens, or even slides, according to Predictive Health. In addition, short-wavelength UV light excites many fluorescent dyes simultaneously for the acquisition of snapshot color images. The result is detailed histology-free images of high resolution, structure, and depth, the company said.

November 8, 2021

AI of pathology slides improves prostate cancer diagnosis

By Joseph Constance

The study suggests that AI has the potential to transform histopathological evaluation and optimize the risk stratification and clinical management of prostate cancer, giving it more of a precision approach, according to the study's authors, from the University of Wisconsin and elsewhere.

November 3, 2021

Deep Bio to collaborate with Morphle Labs

By LabPulse.com staff writers

The agreement is expected to give pathologists access to artificial intelligence (AI)-based prostate-specific tissue image analysis and Morphle Labs' remote microscopy workflow scanners. Morphle Labs is based in Bengaluru, India.

October 31, 2021

Gestalt debuting new version of PathFlow

By LabPulse.com staff writers

PathFlow V4.0 now supports a fully integrated exchange of data, images, and multiple file formats between the workflows of the software's professional, education, and research modules.

October 14, 2021

BioReference buys Roche's prenatal testing business

By LabPulse.com staff writers

BioReference offers a similar test, ClariTest Core, through its specialty health division, GenPath, it said; U.S. Ariosa's Harmony Prenatal will round out the company's prenatal screening portfolio.

August 15, 2021

Lunit receives $26M funding from Guardant Health

By LabPulse.com staff writers

Lunit has developed Lunit Scope, a software application to perform tissue analysis of pathology images stained with hematoxylin and eosin. Lunit researchers recently presented results at the American Society of Clinical Oncology 2021 annual meeting showing that Lunit Scope was able to identify 50% more patients who would respond to immunotherapy compared with traditional diagnostic pathology.

July 18, 2021

Sectra announces order for digital pathology solution

By LabPulse.com staff writers

The providers Sectra will work with include Maastricht University Medical Center, Laurentius Hospital, and VieCuri MC. Sectra's digital pathology solution will be integrated with the laboratory information systems (LIS) used at the different locations.

July 18, 2021

AI model identifies SARS-CoV-2 from blood tests, chest x-rays

By Will Morton

Chinese researchers in Hong Kong designed a machine-learning model using blood tests taken during the first and second wave of infection since the start of the COVID-19 outbreak in April 2020. They found when combined with a radiologist's interpretation of x-rays, the model achieved a very high sensitivity in detecting COVID-19 infections.

July 15, 2021

Hologic gets CE Mark for COVID-19 test

By LabPulse.com staff writers

The Aptima SARS-CoV-2 test is a molecular diagnostic assay that detects the genetic material of the pathogen causing COVID-19 and runs on the fully automated Panther system, Hologic said.

July 14, 2021

Xifin buys Computerized Management Services

By LabPulse.com staff writers

Xifin already has a strong market position in the laboratory billing space, and the Computerized Management Services deal now gives the firm a footprint in medical imaging, according to the company. Xifin sees parallels between both spaces, with both lab and imaging providers forced to deal with growing caseloads while at the same time managing lower reimbursement, client fee reductions, and challenges in claims processing.

July 6, 2021

Third Opinion touts AI disease detection results

By LabPulse.com staff writers

The patented software achieved a median accuracy of 83.8% for classifying 70 types of blood cells and detected 35 out of 70 specific types of blood cells, the company said. It had a 95% accuracy rate in detection of the 35 most common cells for different types of leukemia.

July 1, 2021

Barco launches medical-grade pathology display

By LabPulse.com staff writers

MDPC-8127 is a 27-inch, 8-megapixel, ultrahigh-definition display, according to the company. It was designed exclusively for use in digital pathology and can be integrated into pathology workflows with WSI systems from multiple vendors.

June 28, 2021

Previous Page

Page 3 of 8

Next Page